The CD4 + cell counts in both the treatment-naïve and treatment-experienced groups displayed an increasing trend throughout the treatment period; the CD4 + cell counts were maintained at over 500 cells/μL after 36 months in treatment-naïve patients and after 48 months in treatment-experienced patients.
← all excerpts
Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance.
1
—
—